Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.
Press releases published on April 1, 2025
INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study
GlobeNewswire
·
April 1, 2025
MINDFuL Phase II Blinded, Randomized, Placebo-Controlled Data Anticipated June 2025 Boca Raton, Florida, April 01, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on …
Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
GlobeNewswire
·
April 1, 2025
Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel achieved a 17.1% overall response rate (ORR), including one complete response, compared to 5.3% ORR for paclitaxel alone, in patients with biliary tract cancer (BTC) treated in …
3D Systems Completes Sale of Geomagic Software Portfolio
GlobeNewswire
·
April 1, 2025
Closed transaction for $123 million, with expected net proceeds of approximately $100 million to strengthen balance sheet and invest in future growth and profitability initiatives Sharpens focus on core additive manufacturing software solutions — 3D Sprint …
Medicenna to Present at Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 1, 2025
TORONTO and HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …
Codexis Appoints Cynthia Collins to Board of Directors
GlobeNewswire
·
April 1, 2025
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Cynthia Collins to the Company’s …
Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film
GlobeNewswire
·
April 1, 2025
Reports positive pharmacokinetic (PK) results from the recently completed pediatric study for Anaphylm™ Completes submission of its New Drug Application (NDA) for Anaphylm to the FDA; NDA acceptance expected in Q2 2025 WARREN, N.J., April 01, 2025 (GLOBE …
Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)
GlobeNewswire
·
April 1, 2025
Results support continued development in MDD with concomitant EDS; Phase 3 trial planned in 2025 Approximately 50 percent of MDD patients experience EDS1, highlighting high unmet need NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. ( …
AmpliTech Reports FY 2024 Financial Results
GlobeNewswire
·
April 1, 2025
HAUPPAUGE, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG), a leading designer, developer, and manufacturer of advanced signal-processing components for satellite, 5G, and other communication networks, including complete 5G/6G …
Trust Stamp files its 2024 10-K and gives forward-looking revenue and expense guidance
GlobeNewswire
·
April 1, 2025
Atlanta, GA, April 01, 2025 (GLOBE NEWSWIRE) -- Trust Stamp announces that: It filed its 10-K report for the 2024 Financial Year after the Nasdaq market closed on March 31st, 2025. Q4 2024 Revenue was $1.50m increased from $0.51m for Q3 of 2024 and $0.58m …
Alamos Gold Provides Notice of First Quarter 2025 Results and Conference Call, and Annual General and Special Meeting of Shareholders
GlobeNewswire
·
April 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) plans to release its first quarter 2025 financial results after market close on Wednesday, April 30, 2025. Senior management will host a conference …
Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission
GlobeNewswire
·
April 1, 2025
ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …
BEN, Swiss Life Launch AI Partnership for Global Insurance Solutions
GlobeNewswire
·
April 1, 2025
WILMINGTON, Del., April 01, 2025 (GLOBE NEWSWIRE) -- Brand Engagement Network Inc. (BEN) (Nasdaq: BNAI), an innovator in AI-driven customer engagement solutions, has announced a strategic partnership with Swiss Life Global Solutions. This collaboration …
G2 Drills 43m @ 1.9 g/t Au & 51m @ 1.2 g/t Au in New Discovery Zone
GlobeNewswire
·
April 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- G2 Goldfields Inc. (“G2” or the “Company”) (TSX: GTWO; OTCQX: GUYGF) announces additional diamond drilling results further expanding on the Company’s new discovery at the OKO Project, Guyana. Drilling has …
B2Gold Announces TSX Approval for Normal Course Issuer Bid
GlobeNewswire
·
April 1, 2025
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO) (NYSE American: BTG) (“B2Gold” or the “Company”) announces that, further to the press release of the Company dated January 13, 2025 (the “Announcement PR”), the Toronto …
Verano Expands Connecticut Footprint with Opening of Zen Leaf Ashford, Company’s Sixth Retail Location and Closest Cannabis Dispensary1 to University of Connecticut
GlobeNewswire
·
April 1, 2025
Zen Leaf Ashford will feature exclusive 20% everyday “Higher Education” UConn student discount and celebrate Husky wins with special deals for victories in multiple sports Zen Leaf Ashford, located at 55 Nott Hwy, is the closest dispensary to the …
QuestDB Powers B3 Exchange’s Next-Generation CSD Platform’s Tick Data Store
GlobeNewswire
·
April 1, 2025
SAO PAULO, April 01, 2025 (GLOBE NEWSWIRE) -- B3, the main stock exchange in Brazil and the largest in Latin America, today announced its strategic collaboration with QuestDB to power exchange trading data management for its cutting-edge Central Securities …
ITM Appoints Dr. Celine Wilke as Chief Medical Officer
GlobeNewswire
·
April 1, 2025
Experienced leader in radiopharmaceutical drug development, regulatory, and clinical strategies will advance ITM’s broad pipeline and clinical development strategy Garching / Munich, Germany, April 01, 2025 – ITM Isotope Technologies Munich SE (ITM), a …
Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond
GlobeNewswire
·
April 1, 2025
ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant …
InterDigital to demonstrate “HDR Without Limits” alongside partners at NAB 2025
GlobeNewswire
·
April 1, 2025
WILMINGTON, Del., April 01, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that it will be showcasing high-dynamic range (HDR) video streaming technologies at …
Percona Everest Now Supports Red Hat OpenShift For Open Source Cloud Database Deployments
GlobeNewswire
·
April 1, 2025
RALEIGH, N.C., April 01, 2025 (GLOBE NEWSWIRE) -- Percona, a global leader in enterprise-grade open source database software and services, today announced that Percona Everest now supports deployment on Red Hat OpenShift, the industry’s leading hybrid …